Dr. Farhad Hafezi
Board of Advisors
Farhad Hafezi, MD, PhD, is a corneal and refractive laser surgeon specialized in complication management. Prof. Hafezi is also one of the pioneers of the collagen cross-linking (CXL) treatment method for keratoconus and postoperative ectasia. His research focuses on corneal biomechanics, and CXL; his most recent publications involve the novel method for treating corneal infections using CXL parameters called PACK-CXL (Photo-Activated Chromophore for Keratitis).
Philantrophically, Prof. Hafezi founded an initiative called Light for Sight to eliminate preventable blindness among children and adolescents with keratoconus.
In 2010, Professor Hafezi was appointed Chair and Prof. of Ophthalmology of the University Eye Clinic of Geneva and Eye Clinic Director at the Geneva University Hospitals in Switzerland. In 2012, the faculty of the Keck School of Medicine at the University of Southern California (USC) Los Angeles (Doheny Eye Institute) appointed Professor Hafezi as Clinical Professor of Ophthalmology.
In 2013, Prof. Hafezi was a co-founder and head scientific advisor of the spin-off company from the University of Geneva called EMAGine SA (Zug, Switzerland). This company will bring out the first device to treat corneal infections at the slit lamp using CXL technology.
Prof. Hafezi has published 130 articles and book chapters including articles in Nature Medicine, Nature Genetics and Genes & Development. His work has been cited more than 3,600 times with a total impact factor of 356 (ISI 2012) and h index of 33.